Filing detail
CNS Pharmaceuticals, Inc. 8-K
Accession 0001683168-25-008624
Filed (ET)
Nov 20, 7:00 PM ET
Accepted
Nov 21, 5:19 PM ET
File size
973.3 KB
SEC accession
0001683168-25-008624
Filing details
- Company
- CNS Pharmaceuticals, Inc.
- CIK
- 0001729427
- Incorporated
- NV
- Entity type
- operating
Related parties
- filerCIK 0001729427
Documents
cns_8k.htm
8-K
CURRENT REPORT
PrimaryOpen file ↗cns_ex0301.htm
EX-3.1
CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED ARTICLES OF INCORPORATION
cns_ex1001.htm
EX-10.1
2020 EQUITY PLAN (AS AMENDED AND RESTATED)
cnsp-20251117.xsd
EX-101.SCH
XBRL SCHEMA FILE
cnsp-20251117_lab.xml
EX-101.LAB
XBRL LABEL FILE
cnsp-20251117_pre.xml
EX-101.PRE
XBRL PRESENTATION FILE
image_005.jpg
GRAPHIC
GRAPHIC
image_006.jpg
GRAPHIC
GRAPHIC
image_007.jpg
GRAPHIC
GRAPHIC
image_008.jpg
GRAPHIC
GRAPHIC
R1.htm
XML
IDEA: XBRL DOCUMENT
Show.js
XML
IDEA: XBRL DOCUMENT
report.css
XML
IDEA: XBRL DOCUMENT
FilingSummary.xml
XML
IDEA: XBRL DOCUMENT
MetaLinks.json
JSON
IDEA: XBRL DOCUMENT
0001683168-25-008624-xbrl.zip
ZIP
IDEA: XBRL DOCUMENT
cns_8k_htm.xml
XML
IDEA: XBRL DOCUMENT